Ironic Biotech
PrivateLast Round
Pre Seed
Apr 4, 2024
Total Funding Raised
$1.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ironic Biotech is a food tech company that develops bioavailable, plant-derived heme iron proteins using precision fermentation to address iron deficiency.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ironic Biotech Comparables
Compare Ironic Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| De Novo Foodlabs | 82% | |
| Helaina | 78% | |
| Vivici | 77% | |
Ironic Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Apr 4, 2024 |
Key People
Founding team and executive leadership
Ironic Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nordic Foodtech VC | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 61% MoM.
- Apr 27, 2026
Grew 38% QoQ, from 8 to 11 employees.
Ironic Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ironic Biotech's valuation, stock price, and market status.